Antibiotic resistance: The unfolding crisis

Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance

Volumn , Issue , 2007, Pages 25-38

  Laxminarayan, Ramanan ^a,b,c  

^a RESOURCES FOR THE FUTURE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650224669     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9781936331086     Document Type: Chapter

References (55)

1. Abboud, F. M. and B. A. Waisbren. (1959). "Correlation Between in Vitro Studies and Response to Antibiotic Therapy in Staphylococcic Bacteremia." Archives of Internal Medicine 104(2): 226-233.
2. Arakawa, Y., Y. Ike, et al. (2000). "Trends in Antimicrobial-Drug Resistance in Japan." Emerging Infectious Diseases 6(6).
3. Archer, G. L. (1998). " Staphylococcus aureus: A Well-Armed Pathogen." Clinical Infectious Diseases 26(5): 1179-1181.
4. Arias, C. A., J. Reyes, et al. (2003). "Multicentre Surveillance of Antimicrobial Resistance in Enterococci and Staphylococci from Colombian Hospitals, 2001-2002." The Journal of Antimicrobial Chemotherapy 51(1): 59-68.
5. Armstrong, G. L., L. A. Conn, et al. (1999). "Trends in Infectious Disease Mortality in the United States During the 20th Century." JAMA 281(1): 61-66.
6. Bantar, C., A. Famiglietti, et al. (2004). "Análisis de los Dos Cortes de Prevalencia de los Años 2002 y 2003 [Comparative Analysis During Two Periods of Prevalence from 1999 to 2003]." Bulletins 144, 153, 158, and 167. (In Spanish) Asociación Argentina de Microbiología, Buenos Aires, Argentina. http://www.aam.org.ar/archivos/167_SIR.pdf (accessed May 31, 2006 ).
7. Blot, S. I., K. H. Vandewoude, et al. (2002). "Outcome and Attributable Mortality in Critically Ill Patients with Bacteremia Involving Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus ." Archives of Internal Medicine 162: 2229-2235.
8. Bouchillon, S. K., B. M. Johnson, et al. (2004). "Determining Incidence of Extended Spectrum [Beta]-Lactamase Producing Enterobacteriaceae, Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus in 38 Centres from 17 Countries: the PEARLS Study 2001-2002." International Journal of Antimicrobial Agents 24(2): 119-124.
9. Briggs, S., A. Upton, et al. (2002). "Vancomycin-Resistant Enterococcal Colonisation of Hospitalised Patients in Auckland [Abstract Only]." The New Zealand Medical Journal. 115(1160): U145.
10. CDC (1993). "Nosocomial Enterococci Resistant to Vancomycin-United States, 1989-1993." MMWR. Morbidity and Mortality Weekly Report 42(30): 597-9. Centers for Disease Control and Prevention.
11. CDC. (1999). "National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, Issued June 1999." American Journal of Infection Control 27(6): 520-532.
12. CDC. (2000). "National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-April 2000, Issued June 2000." American Journal of Infection Control 28(6): 429-448.
13. CDC. (2001). "National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, Issued August 2001." American Journal of Infection Control 29(6): 404-421.
14. CDC. (2003). "National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992 Through June 2003, Issued August 2003." American Journal of Infection Control 31(8): 481-498.
15. CDC. (2004). "National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992 Through June 2004, Issued October 2004." American Journal of Infection Control 32(8): 470-485.
16. Chang, S. and D. M. Sievert. (2003). "Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene." The New England Journal of Medicine 348(14): 1342-1347.
17. Cizman, M., B. Beovic, et al. (2004). "Antibiotic Policies in Central Eastern Europe." International Journal of Antimicrobial Agents 24(3): 199-204.
18. Cosgrove, S. E., Y. Qi, et al. (2005). "The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges." Infection Control and Hospital Epidemiology 26: 166-174.
19. Diekema, D. J., M. A. Pfaller, et al. (2000). "Trends in Antimicrobial Susceptibility of Bacterial Pathogens Isolated from Patients with Bloodstream Infections in the USA, Canada and Latin America." International Journal of Antimicrobial Agents 13(4): 257-271.
20. Elbasha, E. H. (2003). "Deadweight Loss of Bacterial Resistance Due to Overtreatment." Health Economics 12(2): 125-138.
21. GAO (1999). Antimicrobial Resistance: Data to Assess Public Health Threat From Resistant Bacteria Are Limited. GAO/HEHS/NSIAD/RCED-99-132. http://www.gao.gov/archive/1999/hx99132.pdf (accessed May 31, 2006 ). U.S. General Accounting Office.
22. Gaynes, R. and J. R. Edwards. (2005). "Overview of Nosocomial Infections Caused by Gram-Negative Bacilli." Clinical Infectious Diseases 41(6): 848-854.
23. Goossens, H., M. Ferech, et al. (2003). "European Surveillance of Antibiotic Consumption (ESAC) Interactive Database." http://www.esac.ua.ac.be (accessed January 20, 2006 ).
24. Herold, B. C., L. C. Immergluck, et al. (1998). "Community-Acquired Methicillin-Resistant Staphylococcus aureus in Children with No Identified Predisposing Risk." JAMA 279(8): 593-598.
25. Ho, P. L. F. (2003). "Carriage of Methicillin-Resistant Staphylococcus aureus, Ceftazidime-Resistant Gram-Negative Bacilli, and Vancomycin-Resistant Enterococci Before and After Intensive Care Unit Admission." Critical Care Medicine 31(4): 1175-1182.
26. Holmberg, S. D., S. L. Solomon, et al. (1987). "Health and Economic Impacts of Antimicrobial Resistance." Reviews of Infectious Diseases 9(Nov.-Dec.): 1065-1078.
27. Howard, D. and K. Rask. (2002). The Impact of Resistance on Antibiotic Demand in Patients with Ear Infections. Battling Resistance to Antibiotics and Pesticides: An Economic Approach. R. Laxminarayan (ed.). Washington, DC: RFF Press, 119-133.
28. Jones, M., D. Draghi, et al. (2004). "Emerging Resistance Among Bacterial Pathogens in the Intensive Care Unit: A European and North American Surveillance Study (2000-2002)." Annals of Clinical Microbiology and Antimicrobials 3(14).
29. Kim, T., P. I. Oh, et al. (2001). "The Economic Impact of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals." Infection Control and Hospital Epidemiology 22(2): 99-104.
30. Klein, E., R. Laxminarayan. (2006). "Hospitalizations and Deaths in the U.S. Due to Vancomycin-Resistant Enterococcal and Methicillin-resistant Staphylococcus aureus Infections, 2004." Working paper. Washington, DC: Resources for the Future.
31. Klein, E., D. L. Smith, et al. (2007). "Trends in Hospitalizations and Deaths in the U.S. due to Staphylococcus aureus and MRSA Infections, 1999-2004." Manuscript submitted for publication.
32. Kuehnert, M. J., H. A. Hill, et al. (2005). "Methicillin-Resistant Staphylococcus aureus Hospitalizations, United States." Emerging Infectious Diseases 11(6): 868-872.
33. Lee, K., Y. A. Kim, et al. (2004). "Increasing Prevalence of Vancomycin-Resistant Enterococci, and Cefoxitin-, Imipenem- and Fluoroquinolone-Resistant Gram-Negative Bacilli: A KONSAR Study in 2002." Yonsei Medical Journal 45(4): 598-608.
34. Liu, G., S. Xu, et al. (2003). "Analysis of Antimicrobial Resistance of Clinical Isolates of Enterococci from Beijing and Other Areas in China [Article in Chinese Abstract Only]." Zhonghua Yi Xue Za Zhi 83(12): 1049-1052.
35. Lowy, F. D. (1998). " Staphylococcus aureus Infections." The New England Journal of Medicine 339(8): 520-532.
36. Matsumoto, T., T. Muratani, et al. (2004). "No Regional Spread of Vancomycin-Resistant Enterococci with vanA or vanB in Kitakyushu, Japan." Journal of Infection and Chemotherapy 10(6): 331-334.
37. McDonald, L. C. (2006). "Trends in Antimicrobial Resistance in Health Care-Associated Pathogens and Effect on Treatment." Clinical Infectious Diseases 42(S2): S65-S71.
38. McDonald, L. C., T. L. Lauderdale, et al. (2004). "The Status of Antimicrobial Resistance in Taiwan Among Gram-Positive Pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) Programme, 2000." International Journal of Antimicrobial Agents 23(4): 362-370.
39. McManus, P., M. L. Hammond, et al. (1997). "Antibiotic Use in the Australian Community, 1990-1995." The Medical Journal of Australia 167(3): 124-127.
40. Melo, M. C. N., M. C. Silva-Carvalho, et al. (2004). "Detection and Molecular Characterization of a Gentamicin-Susceptible, Methicillin-Resistant Staphylococcus aureus (MRSA) Clone in Rio de Janeiro that Resembles the New York/Japanese Clone." Journal of Hospital Infection 58(4): 276-285.
41. National Prescribing Service. (2005). "Antibiotic Prescribing Is Increasingly Judicious." National Prescribing Service Newsletter 40(June). http://www.nps.org.au/resources/NPS_News/news40/news40.pdf (accessed May 31, 2006 ).
42. Nimmo, G. R., J. M. Bell, et al. (2003). "Fifteen Years of Surveillance by the Australian Group for Antimicrobial Resistance (AGAR)." Communicable Diseases Intelligence 27 Suppl: S47-S54.
43. Noskin, G. A., R. J. Rubin, et al. (2005). "The Burden of Staphylococcus aureus Infections on Hospitals in the United States: An Analysis of the 2000 and 2001 Nationwide Inpatient Sample Database." Archives of Internal Medicine 165(15): 1756-1761.
44. Osmon, S., D. Warren, et al. (2003). "The Influence of Infection on Hospital Mortality for Patients Requiring > 48 h of Intensive Care." Chest 124(3): 1021-1029.
45. OTA. (1995). Impact of Antibiotic-Resistant Bacteria: A Report to the U.S. Congress. Washington, DC: Government Printing Office. Office of Technology Assessment.
46. Palumbi, S.R. (2001). "Humans as the World's Greatest Evolutionary Force." Science 293(5536): 1786-1790.
47. Phelps, C. E. (1989). "Bug/Drug Resistance: Sometimes Less Is More." Medical Care 27(2): 194-203.
48. RIVM. (2005). "European Antimicrobial Resistance Surveillance System (EARSS)." http://www.rivm.nl/earss (accessed January 18, 2005 ). The National Institute for Public Health and the Environment.
49. Rubin, R. J., C. A. Harrington, et al. (1999). "The Economic Impact of Staphylococcus aureus in New York City Hospitals." Emerging Infectious Diseases 5(1): 9-17.
50. Skinner, D. and C. S. Keefer. (1941). "Significance of Bacteremia Caused by Staphylococcus aureus ." Archives of Internal Medicine 68: 851-875.
51. Steinman, M. A., R. Gonzales, et al. (2003). "Changing Use of Antibiotics in Community-Based Outpatient Practice, 1991-1999." Annals of Internal Medicine 138: 525-533.
52. The Genesis Report. (1994). The Real War on Drugs: Bacteria Are Winning. New Jersey.
53. Titze-de-Almeida, R., M. R. Filho, et al. (2004). "Molecular Epidemiology and Antimicrobial Susceptibility of Enterococci Recovered from Brazilian Intensive Care Units." The Brazilian Journal of Infectious Diseases 8(3): 197-205.
54. Udo, E. E., N. Al-Sweih, et al. (2003). "Species Prevalence and Antibacterial Resistance of Enterococci Isolated in Kuwait Hospitals." Journal of Medical Microbiology 52(2): 163-168.
55. Weinstein, R. A. (2003). "Antibiotic Resistance in Hospitals and Intensive Care Units: the Problem and Potential Solutions." Seminars in Respiratory and Critical Care Medicine 24(1): 113-120.